Bladder cancer and cancer stem cells: basic science and implications for therapy.

Area of Science:

• Oncology
• Urology
• Cancer Biology

Background:

• Bladder cancer, primarily urothelial carcinoma (UC), is a common malignancy with significant global health implications.
• Most bladder cancers present as non-muscle-invasive (Ta/T1), but progression to muscle-invasive disease (T2-4) drastically worsens survival rates.
• Recurrence is a major concern for Ta tumors, while progression is critical for T1 tumors, highlighting the need for better therapeutic strategies.

Purpose of the Study:

• To review the fundamental science and background of bladder cancer stem cells.
• To explore the role of bladder cancer stem cells in therapeutic resistance.
• To discuss the implications of targeting these cells for current and future bladder cancer treatments.

Main Methods:

• This review synthesizes existing literature on bladder cancer stem cells.
• It examines molecular insights into the pathogenesis of muscle-invasive bladder cancer.
• The focus is on the biological characteristics and therapeutic potential of cancer stem cells.

Main Results:

• Bladder cancer is a heterogeneous disease with distinct clinical challenges for non-muscle-invasive and muscle-invasive stages.
• Cancer stem cells are implicated as key mediators of resistance to existing bladder cancer therapies.
• Identifying and targeting these cells offers a promising avenue for improved treatment outcomes.

Conclusions:

• Detailed molecular understanding of bladder cancer, particularly stem cells, is urgently needed.
• Targeting bladder cancer stem cells may abrogate progression from early-stage disease and minimize recurrence.
• Further research into cancer stem cell biology is essential for advancing bladder cancer therapy.